Literature DB >> 12028830

Marrow protection - transduction of hematopoietic cells with drug resistance genes.

T Moritz1, D A Williams.   

Abstract

Mesh：

Year:  2001        PMID： 12028830     DOI： 10.1080/14653240152584640

Source DB:  PubMed          Journal:  Cytotherapy        ISSN： 1465-3249            Impact factor:   5.414


× No keyword cloud information.
  5 in total

1.  Creation of zebularine-resistant human cytidine deaminase mutants to enhance the chemoprotection of hematopoietic stem cells.

Authors:  Hongmei Ruan; Songbo Qiu; Brian C Beard; Margaret E Black
Journal:  Protein Eng Des Sel       Date:  2016-05-08       Impact factor: 1.650

2.  Deoxycytidine-kinase knockdown as a novel myeloprotective strategy in the context of fludarabine, cytarabine or cladribine therapy.

Authors:  N Lachmann; K Czarnecki; S Brennig; R Phaltane; M Heise; N Heinz; H Kempf; D Dilloo; V Kaever; A Schambach; M Heuser; T Moritz
Journal:  Leukemia       Date:  2015-04-29       Impact factor: 11.528

3.  Tightly regulated 'all-in-one' lentiviral vectors for protection of human hematopoietic cells from anticancer chemotherapy.

Authors:  N Lachmann; S Brennig; R Hillje; H Schermeier; R Phaltane; J Dahlmann; I Gruh; N Heinz; B Schiedlmeier; C Baum; T Moritz
Journal:  Gene Ther       Date:  2015-06-30       Impact factor: 5.250

Review 4.  Myeloprotection by cytidine deaminase gene transfer in antileukemic therapy.

Authors:  Nico Lachmann; Sebastian Brennig; Ruhi Phaltane; Michael Flasshove; Dagmar Dilloo; Thomas Moritz
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

5.  Chemoprotection of murine hematopoietic cells by combined gene transfer of cytidine deaminase (CDD) and multidrug resistance 1 gene (MDR1).

Authors:  Sebastian Brennig; Nico Lachmann; Theresa Buchegger; Miriam Hetzel; Axel Schambach; Thomas Moritz
Journal:  J Exp Clin Cancer Res       Date:  2015-12-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.